ARTICLE | Company News
SkyePharma gets Canadian distributor for DepoCyt
July 6, 2000 7:00 AM UTC
SkyePharma (LSE:SKP; SKYE) granted exclusive marketing and distribution rights in Canada to Paladin Labs (TSE:PLB) for DepoCyt sustained-release cytarabine to treat neoplastic meningitis. PLB will pay...